XML 38 R25.htm IDEA: XBRL DOCUMENT v3.25.1
Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2025
Accounting Policies [Abstract]  
Schedule of Restricted Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheet (in thousands):
March 31, 2025December 31, 2024
Cash and cash equivalents$227,569 $28,670 
Restricted cash, non-current— 64 
Total cash, cash equivalents and restricted cash $227,569 $28,734 
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents and restricted cash reported within the condensed consolidated balance sheet (in thousands):
March 31, 2025December 31, 2024
Cash and cash equivalents$227,569 $28,670 
Restricted cash, non-current— 64 
Total cash, cash equivalents and restricted cash $227,569 $28,734 
Schedule of Inventory
Details of inventory are presented as follows (in thousands):
March 31, 2025December 31, 2024
Raw materials$— $3,533 
Work in process— — 
Finished goods— 1,778 
Total $— $5,311 
Schedule of Property, Plant and Equipment
Details of property and equipment are presented as follows (in thousands):
March 31, 2025December 31, 2024
Computers and Software$341 $470 
Construction in process— 6,590 
Furniture and fixtures36 65 
Lab equipment— 51 
Leasehold improvements— 133 
Total$377 $7,309 
Accumulated depreciation(352)(463)
Property and equipment, net$25 $6,846 
Schedule Of Gross-To-Net Sales Adjustments
The following table sets forth the changes in the accrued revenue allowances (in thousands):
As of March 31,
20252024
Balance at beginning of period$1,411$1,065
Provision for current period sales2,0851,084
Payments(1,686)(1,292)
Allowances transferred in sale of Aadi Subsidiary, Inc.(1,810)—
Balance at end of period$—$857
Schedule of Earnings Per Share, Basic and Diluted
The computations for basic and diluted EPS were as follows (in thousands, except shares and per share amounts):
Three Months Ended March 31,
20252024
Net income (loss) for basic and diluted EPS$73,016 $(18,289)
Weighted-average shares for basic EPS39,640,826 26,980,698 
Effect of dilutive stock options192,692 — 
Effect of dilutive restricted stock units99,021 — 
Weighted-average shares for diluted EPS39,932,539 26,980,698 
Net income (loss) per share:
  Basic EPS$1.84 $(0.68)
  Diluted EPS$1.83 $(0.68)